A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery

Key facts

Sponsor

Zhe Meng

Principal Investigator

meng zhe

Wuhan University

Intervention

Tubeless laparoscopic adrenalectomy(procedure)

Enrollment

200 enrolled

Eligibility

18-70 years · All sexes

Timeline

2024 – 2027

Study locations (1)

• Zhongnan hospital, Wuhan, Hubei, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Adrenal Cushing syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT07168122
  Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
  Shanghai 6th People's Hospital
• RECRUITINGNANCT05911620
  Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism
  Central Hospital, Nancy, France
• RECRUITINGNANCT05881005
  NAC- NAFLD and Cushing
  University Hospital, Angers
• RECRUITINGNCT06050057
  Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy
  University Hospital Olomouc
• RECRUITINGNCT05521529
  Cushing's Syndrome Before and After Treatment (CORRECT)
  University of Aarhus
• ACTIVE NOT RECRUITINGNCT05446779
  Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
  Helsinki University Central Hospital
• RECRUITINGPHASE2NCT03708900
  Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
  RECORDATI GROUP
• RECRUITINGPHASE4NCT06801249
  Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
  IRCCS Azienda Ospedaliero-Universitaria di Bologna

See all trials for Adrenal Cushing syndrome →